These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3610904)

  • 21. Comparison of cefodizime with various cephalosporins for their indirect effect on the human neutrophil oxidative burst in vitro.
    Labro MT; el Benna J
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():49-57. PubMed ID: 2127416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Activity of fourth generation cephalosporins against clinical isolates of Enterobacteriaceae].
    Tuchiluş C; Poiată A; Bădicuţ I; Teodor A; Luca V; Grigore L; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):595-8. PubMed ID: 14756068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergism and antagonism of ceftizoxime and other new cephalosporins.
    Moellering RC; Willey S; Eliopoulos GM
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():69-79. PubMed ID: 6296032
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative in vitro activity of the new macrolide A-56268 against anaerobic bacteria.
    Wexler HM; Finegold SM
    Eur J Clin Microbiol; 1987 Aug; 6(4):492-4. PubMed ID: 2959473
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative bacteriostatic and bactericidal activities of cefodizime against Borrelia burgdorferi sensu lato.
    Murgia R; Marchetti F; Cinco M
    Antimicrob Agents Chemother; 1999 Dec; 43(12):3030-2. PubMed ID: 10582905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vitro antibacterial activity of a new cephalosporin: cefpirome (HR 810). Comparison with ceftriaxone, cefotaxime, latamoxef and ceftazidime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):567-71. PubMed ID: 3534744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In vitro antibacterial activity of cefodizime (HR 221) on 323 hospital strains of Gram negative bacilli. Comparison with cefotiam, cefoperazone, cefotetan and cefotaxime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1985 May; 33(5):399-403. PubMed ID: 3897972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative in vitro activities of gemifloxacin, other quinolones, and nonquinolone antimicrobials against obligately anaerobic bacteria.
    Kleinkauf N; Ackermann G; Schaumann R; Rodloff AC
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1896-9. PubMed ID: 11353648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of carbon dioxide on the in vitro activity of erythromycin and RU-28965 against anaerobic bacteria.
    Felmingham D; Robbins MJ; Marais R; Ridgway GL; Gruneberg RN
    Drugs Exp Clin Res; 1987; 13(4):195-9. PubMed ID: 3113907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-vitro activity of cefodizime against respiratory pathogens.
    Wise R; Andrews JM; Ashby JP
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():9-12. PubMed ID: 2127417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative in vitro activity of carumonam (Ro 17-2301/AMA-1080), a new monobactam, and ceftriaxone against aerobic or facultative gram-negative isolates.
    Barclay CA; Iribarren MA; Goldberg M; Traballi CA; Casellas JM
    Chemotherapy; 1987; 33(3):165-71. PubMed ID: 3595259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [In vitro activity of a new 3d-generation cephalosporin, cefodizime, on hospital bacteria].
    Soussy CJ; Otterbein G; Le Van Thoi J; Duval J; Chanal M; Cluzel M; Sirot D
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):561-6. PubMed ID: 3534743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carumonam's in-vitro activity against gram-negative bacteria and its stability to their beta-lactamases.
    Raimondi A; Mattina R; Cocuzza CE
    Chemioterapia; 1988 Feb; 7(1):3-9. PubMed ID: 3288365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative in vitro activities of four macrolides: josamycin, erythromycin, spiramycin and roxithromycin, against 424 anaerobic bacteria.
    Derriennic M; Dubreuil L; Reynaud AE; Courtieu AL
    Chemioterapia; 1987 Jun; 6(2 Suppl):159-60. PubMed ID: 3509376
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparative in vitro activity of 2 monobactams (RO 172301 (AMA 1080)and aztreonam), ceftazidime and cefotaxime on Gram-negative bacilli].
    Thabaut A; Meyran M; Huerre M
    Pathol Biol (Paris); 1985 May; 33(5):404-7. PubMed ID: 3929217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decrease in surface charge density of Klebsiella pneumoniae treated with cefodizime and enhancement of the phagocytic function of human polymorphonuclear leucocytes stimulated by the drug-treated bacteria.
    Muratsugu M; Miyake Y; Ishida N; Hyodo A; Terayama K
    Biol Pharm Bull; 1995 Sep; 18(9):1259-63. PubMed ID: 8845818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime.
    Nomura S; Nagayama A
    Chemotherapy; 1995; 41(4):267-75. PubMed ID: 7555207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactam.
    Jones RN; Barry AL; Thornsberry C; Fuchs PC; Packer RR
    Am J Clin Pathol; 1986 Nov; 86(5):608-18. PubMed ID: 3096130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Midecamycin activity against aerobic and anaerobic bacteria].
    Dubini F; Balsari A
    G Ital Chemioter; 1985; 32(3):539-44. PubMed ID: 3836904
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparative antibacterial activity of cefpodoxime, cefuroxime and cefaclor against strict anaerobic bacteria].
    Dubreuil L; Derriennic M; Sedallian A
    Pathol Biol (Paris); 1990 May; 38(5):343-6. PubMed ID: 2367150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.